Synchronized cardioversion is a procedure that delivers a carefully timed electrical shock to the heart to correct an abnormal rhythm. Unlike defibrillation, which shocks the heart at any random point in its cycle, synchronized cardioversion reads the heart’s electrical activity and times the shock to land at a specific safe moment. This distinction matters because shocking at the wrong moment can actually trigger a more dangerous rhythm in someone whose heart is still beating.
How the Timing Works
Your heart’s electrical cycle has distinct phases, visible as waves on a heart monitor. The key concern is a phase called the T wave, which represents the brief window when the heart muscle is resetting and is electrically vulnerable. If a shock hits during the T wave, it can send the heart into a chaotic, life-threatening rhythm called ventricular fibrillation. This is known as the “R-on-T phenomenon.”
Synchronized cardioversion avoids this by using sensors that detect the R wave, a tall spike on the monitor that represents the main contraction of the heart. The machine waits until it detects an R wave, then delivers the shock at that safer point in the cycle. There’s a slight delay between pressing the button and the actual shock because the device is waiting for the right moment. This built-in safety mechanism is what makes the procedure appropriate for people who still have a pulse and a functioning, if irregular, heartbeat.
Synchronized Cardioversion vs. Defibrillation
These two procedures use the same basic equipment but serve different situations. Defibrillation is for cardiac arrest, when the heart has stopped pumping effectively and the person has no pulse. The shock fires the instant the button is pressed, regardless of where the heart is in its cycle, because speed is the priority and there’s no organized rhythm to protect.
Synchronized cardioversion is for people who still have a pulse but whose heart is beating in a fast or irregular pattern that’s causing problems like dangerously low blood pressure, chest pain, or shortness of breath. It also uses less energy. Where defibrillation typically starts at 200 joules or higher, cardioversion often begins at 50 to 200 joules depending on the rhythm being treated.
Which Heart Rhythms It Treats
Synchronized cardioversion is used for several types of abnormal heart rhythms. The most common is atrial fibrillation, where the upper chambers of the heart quiver chaotically instead of contracting in an organized way. It’s also used for atrial flutter, a related but more regular abnormal rhythm in the upper chambers, and for other types of fast heart rhythms originating above the ventricles (collectively called supraventricular tachycardias). Stable ventricular tachycardia, a fast rhythm from the lower chambers in a patient who still has a pulse, can also be treated this way.
The energy settings differ by rhythm. American Heart Association guidelines recommend starting at 120 to 200 joules for atrial fibrillation using modern biphasic machines. Atrial flutter and other supraventricular tachycardias generally respond to less energy, often 50 to 100 joules as an initial dose. If the first shock doesn’t work, the energy is increased in steps and the procedure repeated.
How Effective It Is
Success depends heavily on how long the abnormal rhythm has been going on. For atrial fibrillation lasting three days or less, cardioversion restores a normal rhythm about 77% of the time. That rate drops to around 60% when the rhythm has persisted for more than three months. Overall, studies show an initial success rate of roughly 66% across all durations. This is one reason doctors prefer to attempt cardioversion sooner rather than later when it’s indicated.
Even when cardioversion succeeds initially, the abnormal rhythm can return. Long-term maintenance often involves medications or other treatments to keep the heart in its normal pattern.
Blood Clot Risk and Anticoagulation
One of the most important considerations with cardioversion is the risk of stroke. When the upper chambers of the heart fibrillate instead of contracting properly, blood can pool and form clots. Restoring a normal rhythm can then dislodge those clots, sending them to the brain or elsewhere. The stroke risk is highest in the first two weeks after the procedure, roughly seven times higher than in the following year, according to a nationwide study that tracked over 9,000 patients.
To reduce this risk, guidelines from the American College of Cardiology and American Heart Association call for at least three weeks of blood-thinning medication before cardioversion, followed by a minimum of four weeks afterward. This applies when atrial fibrillation has lasted more than 48 hours or when its duration is uncertain.
For episodes lasting less than 48 hours, the picture is more nuanced than it once was. Doctors previously considered short episodes low risk, but newer data shows that stroke risk isn’t uniformly low in this group. People with additional risk factors for stroke, measured using a scoring system that accounts for age, heart failure history, high blood pressure, diabetes, and prior strokes, face meaningfully higher risk even with brief episodes. Current guidelines recommend factoring in these individual risk profiles rather than relying solely on the 48-hour cutoff.
What the Procedure Feels Like
Synchronized cardioversion is performed while you’re briefly sedated. You won’t be under general anesthesia, but you’ll receive medication through an IV that makes you drowsy and unlikely to remember the shock. The sedation is short-acting, typically wearing off within minutes to a half hour after the procedure.
Two large adhesive electrode pads are placed on your chest. They can be positioned front-and-side (one below the right collarbone, one on the left side of the chest) or front-and-back. Both positions are effective, and the choice depends on your body type and the clinical situation. The machine is set to “sync” mode, the energy level is selected, and the shock is delivered. The whole active portion of the procedure takes only seconds, though preparation and monitoring add time around it.
Recovery and Monitoring
After the shock, you’re monitored for at least an hour to confirm your heart stays in a normal rhythm and that the sedation wears off safely. Most people go home the same day. You may notice mild redness or irritation on your skin where the electrode pads were placed, but this typically fades quickly. Because of the sedation, you’ll need someone to drive you home.
The post-procedure period requires continued blood-thinning medication for at least four weeks, even if the cardioversion was successful. This is because the upper chambers of the heart can be temporarily “stunned” after being shocked back into rhythm, meaning they don’t contract with full force right away. During this recovery window, the risk of clot formation remains elevated. Your doctor will determine whether you need to continue blood thinners beyond that initial month based on your overall stroke risk profile.